Gks Consturction Aids Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.85 M
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.71 Cr
- Revenue Growth 67.46%
- Profit Growth -44.34%
- Ebitda -48.03%
- Net Worth 20.85%
- Total Assets -0.57%
About Gks Consturction Aids
Gks Consturction Aids Private Limited (GCAPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 1996 and has a history of 28 years and five months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.85 M.
The company currently has active open charges totaling ₹18.71 Cr.
Alampalli Prasad, Alampalli Prasad, and Vijayalakshmi Hariprasad serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U45309TN1996PTC036364
-
Company No.
036364
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Aug 1996
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Gks Consturction Aids?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Alampalli Prasad | Director | 13-Aug-1997 | Current |
Alampalli Prasad | Director | 11-Apr-2008 | Current |
Vijayalakshmi Hariprasad | Director | 21-Aug-1996 | Current |
Financial Performance of Gks Consturction Aids.
Gks Consturction Aids Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 67.46% increase. The company also saw a substantial fall in profitability, with a 44.34% decrease in profit. The company's net worth Soared by an impressive increase of 20.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Gks Consturction Aids?
In 2019, Gks Consturction Aids had a promoter holding of 87.06% and a public holding of 12.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹187.10 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 18.71 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
15 May 2008 | Union Bank Of India | ₹18.71 Cr | Open |
How Many Employees Work at Gks Consturction Aids?
Unlock and access historical data on people associated with Gks Consturction Aids, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gks Consturction Aids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gks Consturction Aids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.